| Primary |
| Hypertension |
54.4% |
| Type 2 Diabetes Mellitus |
11.7% |
| Depression |
5.5% |
| Diabetes Mellitus |
4.4% |
| Glaucoma |
2.9% |
| Essential Hypertension |
2.6% |
| Breast Cancer |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Prophylaxis |
1.8% |
| Autoimmune Thyroiditis |
1.5% |
| Fluid Retention |
1.5% |
| Hypothyroidism |
1.5% |
| Arrhythmia |
1.1% |
| Blood Glucose |
1.1% |
| Cough |
1.1% |
| Gout |
1.1% |
| Heart Rate Increased |
1.1% |
| Insomnia |
1.1% |
| Osteoporosis |
1.1% |
| Pyrexia |
1.1% |
|
| Hyponatraemia |
13.2% |
| Hypertension |
7.4% |
| Vomiting |
7.4% |
| Nausea |
5.9% |
| Cataract |
4.4% |
| Fall |
4.4% |
| Hypokalaemia |
4.4% |
| Hypotension |
4.4% |
| Neuropathy Peripheral |
4.4% |
| Product Substitution Issue |
4.4% |
| Rash |
4.4% |
| Renal Failure Chronic |
4.4% |
| Renal Impairment |
4.4% |
| Syncope |
4.4% |
| Vertigo |
4.4% |
| Vision Blurred |
4.4% |
| Weight Decreased |
4.4% |
| Aortic Valve Stenosis |
2.9% |
| Breast Cancer |
2.9% |
| Chest Pain |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
44.0% |
| Hypertension |
19.2% |
| Type 2 Diabetes Mellitus |
9.1% |
| Drug Use For Unknown Indication |
8.8% |
| Depression |
2.7% |
| Atrial Fibrillation |
1.9% |
| Osteoarthritis |
1.6% |
| Anxiety |
1.1% |
| Blood Pressure |
1.1% |
| Dyslipidaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Gout |
1.1% |
| Pain |
1.1% |
| Prostate Cancer |
1.1% |
| Prostatic Disorder |
1.1% |
| Angina Pectoris |
0.8% |
| Myalgia |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Thrombosis Prophylaxis |
0.8% |
| Agitation |
0.5% |
|
| Hyponatraemia |
9.4% |
| Hepatic Cirrhosis |
7.5% |
| Hypokalaemia |
7.5% |
| Pancreatic Carcinoma |
7.5% |
| Completed Suicide |
5.7% |
| Interstitial Lung Disease |
5.7% |
| Pain In Extremity |
5.7% |
| Renal Impairment |
5.7% |
| Acidosis |
3.8% |
| Blood Creatine Phosphokinase Increased |
3.8% |
| Colitis Microscopic |
3.8% |
| Dehydration |
3.8% |
| General Physical Health Deterioration |
3.8% |
| Hypotension |
3.8% |
| Nervous System Surgery |
3.8% |
| Rash |
3.8% |
| Renal Failure Acute |
3.8% |
| Rhabdomyolysis |
3.8% |
| Suicide Attempt |
3.8% |
| Syncope |
3.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.2% |
| Hypertension |
16.4% |
| Product Used For Unknown Indication |
14.8% |
| Prophylaxis |
4.8% |
| Diabetes Mellitus |
4.6% |
| Multiple Myeloma |
4.4% |
| Rheumatoid Arthritis |
4.1% |
| Type 2 Diabetes Mellitus |
2.6% |
| Anxiety |
2.5% |
| Atrial Fibrillation |
2.3% |
| Pyrexia |
2.3% |
| Osteoporosis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Hepatitis C |
2.0% |
| Asthma |
1.5% |
| Bronchopulmonary Aspergillosis |
1.5% |
| Blood Pressure |
1.2% |
| Hypothyroidism |
1.2% |
| Coronary Artery Disease |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Flushing |
8.7% |
| Anaemia |
7.8% |
| Myalgia |
6.8% |
| Renal Failure Chronic |
6.8% |
| Bradycardia |
5.8% |
| Convulsion |
4.9% |
| Death |
4.9% |
| Drug Interaction |
4.9% |
| Dyspnoea |
4.9% |
| International Normalised Ratio Increased |
4.9% |
| Lactic Acidosis |
4.9% |
| Malaise |
4.9% |
| Agitated Depression |
3.9% |
| Confusional State |
3.9% |
| Diarrhoea |
3.9% |
| Haemorrhage |
3.9% |
| Hypotension |
3.9% |
| Oedema Peripheral |
3.9% |
| Paraesthesia |
3.9% |
| Asthenia |
2.9% |
|
| Interacting |
| Arthralgia |
23.5% |
| Hypertension |
23.5% |
| Pain In Extremity |
17.6% |
| Adjustment Disorder With Depressed Mood |
11.8% |
| Pain |
11.8% |
| Depression |
5.9% |
| Gastritis |
5.9% |
|
| Renal Failure Acute |
27.3% |
| Acidosis |
9.1% |
| Blood Creatinine Increased |
9.1% |
| Drug Interaction |
9.1% |
| Dyspnoea |
9.1% |
| Fall |
9.1% |
| Malaise |
9.1% |
| Pain In Extremity |
9.1% |
| Rhabdomyolysis |
9.1% |
|
